Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026

Go back to Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
SmartPros Ltd. (NASDAQ: SPRO) Delayed: 1.19 -0.02 (1.65%)
Previous Close $1.21    52 Week High $3.85 
Open $1.21    52 Week Low $1.25 
Day High $1.22    P/E N/A 
Day Low $1.19    EPS $-0.28 
Volume 348,590